To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

Completed · Phase 2 · Has a placebo group

Conditions studied: Moderate to Severe Plaque Psoriasis

In brief

This is a multicenter, randomized, double-blind, placebo-controlled study in subjects with moderate to severe plaque psoriasis.

Key facts

Study ID
NCT04566666
Run by
Sun Pharmaceutical Industries Limited
People needed
263
Starts
2021-03-25
Expected to finish
2025-08-27
Last updated by the study team
2026-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.